BCL-X
L
is a BCL-2 family anti-apoptotic protein that functions as a targetable dependency in clear cell Renal Cell Carcinoma (ccRCC), the most common form of adult kidney cancer. However, the mechanisms driving this dependence are unclear. Moreover, although significant strides have been made in managing ccRCC,...
Tupa Basuroy, Treg M. Grubb, Ananthan Sadagopan et al.· Cell Death & Disease· 0 citations
Ligand-protein binding prediction remains a central challenge, yet the contribution of ligand-side information to performance is unclear and ligand-only models as interpretable screening tools are established and used as a baseline for assessing the added value of protein representations.
Ananthan Sadagopan, Anurag Sodhi, William J. Gibson· Journal of Medicinal Chemist...· 0 citations
It is demonstrated that machine learning applied to transcriptomic data can uncover novel cancer vulnerabilities and actionable targets in individual tumors, even in the absence of functional screening, which may represent a scalable approach to advance precision oncology in rare and/or under-characterized cancer types...
Ananthan Sadagopan, Bingchen Li, Jiao Li et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.